BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2763429)

  • 1. Flunixin pharmacokinetics and serum thromboxane inhibition in the dog.
    McKellar QA; Galbraith EA; Bogan JA; Russell CS; Hooke RE; Lees P
    Vet Rec; 1989 Jun; 124(25):651-4. PubMed ID: 2763429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flunixin in the cat: a pharmacodynamic, pharmacokinetic and toxicological study.
    Taylor PM; Winnard JG; Jefferies R; Lees P
    Br Vet J; 1994; 150(3):253-62. PubMed ID: 8044665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of flunixin in the horse: its relationship to thromboxane B2 production.
    Soma LR; Uboh CE; Rudy J; Fegely J
    J Vet Pharmacol Ther; 1992 Sep; 15(3):292-300. PubMed ID: 1433493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein binding and in vitro serum thromboxane B2 inhibition by flunixin meglumine and meclofenamic acid in dog, goat and horse blood.
    Galbraith EA; McKellar QA
    Res Vet Sci; 1996 Jul; 61(1):78-81. PubMed ID: 8819199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunixin meglumine given in small doses: pharmacokinetics and prostaglandin inhibition in healthy horses.
    Semrad SD; Hardee GE; Hardee MM; Moore JN
    Am J Vet Res; 1985 Dec; 46(12):2474-9. PubMed ID: 4083579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of and serum thromboxane suppression by flunixin meglumine in healthy foals during the first month of life.
    Semrad SD; Sams RA; Ashcraft SM
    Am J Vet Res; 1993 Dec; 54(12):2083-7. PubMed ID: 8116942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of flunixin meglumine injectable preparation administered orally to healthy horses.
    Pellegrini-Masini A; Poppenga RH; Sweeney RW
    J Vet Pharmacol Ther; 2004 Jun; 27(3):183-6. PubMed ID: 15189304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PHARMACOKINETICS OF A SINGLE ORAL DOSE OF FLUNIXIN MEGLUMINE IN THE WHITE RHINOCEROS (
    East B; Tell L; Citino SB; Fredholm DV; Gamble K; Fajt V
    J Zoo Wildl Med; 2019 Jun; 50(2):322-329. PubMed ID: 31260196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics and pharmacokinetics of flunixin in the cat.
    Lees P; Taylor PM
    Br Vet J; 1991; 147(4):298-305. PubMed ID: 1913126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and effects on thromboxane B2 production following intravenous administration of flunixin meglumine to exercised thoroughbred horses.
    Knych HK; Arthur RM; McKemie DS; Chapman N
    J Vet Pharmacol Ther; 2015 Aug; 38(4):313-20. PubMed ID: 25582761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and excretion of flunixin meglumine in horses.
    Soma LR; Behrend E; Rudy J; Sweeney RW
    Am J Vet Res; 1988 Nov; 49(11):1894-8. PubMed ID: 3247913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of flunixin meglumine in lactating cattle after single and multiple intramuscular and intravenous administrations.
    Anderson KL; Neff-Davis CA; Davis LE; Bass VD
    Am J Vet Res; 1990 Sep; 51(9):1464-7. PubMed ID: 2396794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of multiple doses of transdermal flunixin meglumine in adult Holstein dairy cows.
    Kleinhenz MD; Gorden PJ; Smith JS; Schleining JA; Kleinhenz KE; Wulf LL; Sidhu PK; Rea D; Coetzee JF
    J Vet Pharmacol Ther; 2018 Jun; 41(3):490-493. PubMed ID: 29460288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of flunixin meglumine in the sheep.
    Welsh EM; McKellar QA; Nolan AM
    J Vet Pharmacol Ther; 1993 Jun; 16(2):181-8. PubMed ID: 8345568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacokinetics of transdermal flunixin meglumine in Holstein calves.
    Kleinhenz MD; Van Engen NK; Gorden PJ; KuKanich B; Rajewski SM; Walsh P; Coetzee JF
    J Vet Pharmacol Ther; 2016 Dec; 39(6):612-615. PubMed ID: 27121728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of piroxicam in dogs.
    Galbraith EA; McKellar QA
    Vet Rec; 1991 Jun; 128(24):561-5. PubMed ID: 1887556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.
    Hardee MM; Moore JN; Hardee GE
    Res Vet Sci; 1986 Mar; 40(2):152-6. PubMed ID: 3517992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Firocoxib, Flunixin Meglumine, and Phenylbutazone on Platelet Function and Thromboxane Synthesis in Healthy Horses.
    Burkett BN; Thomason JM; Hurdle HM; Wills RW; Fontenot RL
    Vet Surg; 2016 Nov; 45(8):1087-1094. PubMed ID: 27731498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PHARMACOKINETICS OF ORALLY ADMINISTERED FLUNIXIN MEGLUMINE IN AFRICAN (
    Bechert U; Christensen JM; Kottwitz J; Boothe D; Alshahrani S; Mohammed S
    J Zoo Wildl Med; 2021 Jan; 51(4):905-914. PubMed ID: 33480571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.